Davies, M. J. et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 65, 1925–1966 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powers, M. A. et al. Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. J. Acad. Nutr. Diet. 121, 773–788.e9 (2021).

Article  PubMed  Google Scholar 

Powers, M. A. 2016 Health Care & Education Presidential address: If DSME Were a Pill, Would You Prescribe It? Diabetes Care 39, 2101–2107 (2016).

Article  PubMed  Google Scholar 

Chrvala, C. A., Sherr, D. & Lipman, R. D. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ. Couns. 99, 926–943 (2016).

Article  PubMed  Google Scholar 

Fisher, L. et al. REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care 36, 2551–2558 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee, S. et al. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 6, 130–142 (2018).

Article  PubMed  Google Scholar 

Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. W. 10-Year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).

Article  CAS  PubMed  Google Scholar 

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998).

Article  Google Scholar 

Khunti, K., Ceriello, A., Cos, X. & Block, C. D. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res. Clin. Pr. 137, 137–148 (2018).

Article  Google Scholar 

American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes—2022. Diabetes Care 45, S83–S96 (2021).

Article  Google Scholar 

Lind, M., Imberg, H., Coleman, R. L., Nerman, O. & Holman, R. R. Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88. Diabetes Care 44, 2231–2237 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paul, S. K., Klein, K., Thorsted, B. L., Wolden, M. L. & Khunti, K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc. Diabetol. 14, 100 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Mateo, J. F. et al. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int. J. Clin. Pract. 60, 422–428 (2006).

Article  CAS  PubMed  Google Scholar 

Safford, M. M. et al. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J. Gen. Intern. Med. 22, 1648–1655 (2007).

Article  PubMed  PubMed Central  Google Scholar 

Khunti, K. et al. Clinical inertia in intensifying therapy among people with type 2 diabetes treated with basal insulin. Diabetes Obes. Metab. 18, 401–409 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seidu, S. et al. Therapeutic inertia amongst general practitioners with interest in diabetes. Prim. Care Diabetes 12, 87–91 (2018).

Article  PubMed  Google Scholar 

Khunti, K. & Davies, M. J. Clinical inertia – time to reappraise the terminology? Prim. Care Diabetes 11, 105–106 (2017).

Article  PubMed  Google Scholar 

Doyle-Delgado, K., Chamberlain, J. J., Shubrook, J. H., Skolnik, N. & Trujillo, J. Pharmacologic approaches to glycemic treatment of type 2 diabetes: synopsis of the 2020 American Diabetes Association’s Standards of Medical Care in Diabetes Clinical Guideline. Ann. Intern. Med. 173, 813–821 (2020).

Article  PubMed  Google Scholar 

National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. NICE guideline [NG28]. nice.org.uk www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493 (2022).

Khunti, K. et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes. Metab. 20, 427–437 (2018).

Article  PubMed  Google Scholar 

Kaewbut, P. et al. Time to treatment intensification to reduce diabetes-related complications: a post hoc study. Healthcare 10, 1673 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Bain, S. C., Hansen, B. B., Hunt, B., Chubb, B. & Valentine, W. J. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. J. Med. Econ. 23, 98–105 (2019).

Article  PubMed  Google Scholar 

Tsotra, F. et al. The societal impact of early intensified treatment in patients with type 2 diabetes mellitus. J. Comp. Eff. Res. 11, 1185–1199 (2022).

Article  CAS  PubMed  Google Scholar 

Ward, J. E. F., Stetson, B. A. & Mokshagundam, S. P. L. Patient perspectives on self-monitoring of blood glucose: perceived recommendations, behaviors and barriers in a clinic sample of adults with type 2 diabetes. J. Diabetes Metab. Disord. 14, 43 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Polonsky, W. H., Fisher, L., Hessler, D. & Edelman, S. V. What is so tough about self‐monitoring of blood glucose? Perceived obstacles among patients with type 2 diabetes. Diabet. Med. 31, 40–46 (2014).

Article  CAS  PubMed  Google Scholar 

Monnier, L., Colette, C., Dunseath, G. J. & Owens, D. R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30, 263–269 (2007).

Article  PubMed  Google Scholar 

Monnier, L., Colette, C., Dejager, S. & Owens, D. The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice? Diabetes Metab. 41, 132–137 (2015).

Article  CAS  PubMed  Google Scholar 

Monnier, L., Colette, C. & Owens, D. R. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab. Res. Rev. 25, 393–402 (2009).

Article  CAS  PubMed  Google Scholar 

Monnier, L., Colette, C. & Owens, D. Three key indices in clinical practice to better comprehend the postprandial and basal glucose contributions in type 2 diabetes. Diabetes Technol. Ther. 24, 853–855 (2022).

Article  PubMed  Google Scholar 

Monnier, L., Colette, C., Dejager, S. & Owens, D. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes. Diabetes Care 36, 4057–4062 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monnier, L., Colette, C. & Owens, D. Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts. Diabetes Technol. Ther. 13, S25–S32 (2011).

Article  PubMed  Google Scholar 

Monnier, L., Colette, C., Dejager, S. & Owens, D. Residual dysglycemia when at target HbA1c of 7% (53 mmol/mol) in persons with type 2 diabetes. Diabetes Res. Clin. Pr. 104, 370–375 (2014).

Article  CAS  Google Scholar 

Monnier, L., Lapinski, H. & Colette, C. Contriutions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 26, 881–885 (2003).

Article  PubMed  Google Scholar 

Riddle, M., Umpierrez, G., DiGenio, A., Zhou, R. & Rosenstock, J. Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 34, 2508–2514 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riddle, M. C. The treat-to-target trial and related studies. Endocr. Pract. 12, 71–79 (2006).

Article  PubMed  Google Scholar 

Monnier, L., Wojtusciszyn, A., Colette, C. & Owens, D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol. Ther. 13, 813–818 (2011).

Article  CAS  PubMed  Google Scholar 

Uemura, F., Okada, Y., Torimoto, K. & Tanaka, Y. Relation between hypoglycemia and glycemic variability in type 2 diabetes patients with insulin therapy: a study based on continuous glucose monitoring. Diabetes Technol. Ther. 20, 140–146 (2018).

Article  CAS  PubMed  Google Scholar 

Uemura, F. et al. Risk factor analysis for type 2 diabetes patients about hypoglycemia using continuous glucose monitoring: results from a prospective observational study. Diabetes Technol. Ther. 24, 435–445 (2022).